Denali Therapeutics Inc (DNLI)
15.56
-0.55
(-3.41%)
USD |
NASDAQ |
Apr 24, 16:00
15.55
-0.01
(-0.06%)
After-Hours: 20:00
Denali Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -7.84K% |
| June 30, 2023 | 62.35% |
| March 31, 2023 | -312.4% |
| December 31, 2022 | -959.6% |
| September 30, 2022 | -2.90K% |
| June 30, 2022 | -112.0% |
| March 31, 2022 | -154.8% |
| December 31, 2021 | -601.4% |
| September 30, 2021 | -1.60K% |
| June 30, 2021 | -264.6% |
| March 31, 2021 | -884.0% |
| December 31, 2020 | 77.30% |
| Date | Value |
|---|---|
| September 30, 2020 | -619.9% |
| June 30, 2020 | -1.00K% |
| March 31, 2020 | -1.58K% |
| December 31, 2019 | -1.16K% |
| September 30, 2019 | -340.0% |
| June 30, 2019 | -1.39K% |
| March 31, 2019 | -927.3% |
| December 31, 2018 | 61.69% |
| September 30, 2018 | -2.96K% |
| June 30, 2018 | -3.32K% |
| March 31, 2018 | -3.69K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.84K%
Minimum
Sep 2023
77.30%
Maximum
Dec 2020
-1.20K%
Average
-752.0%
Median
Profit Margin (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 37.12% |
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Armata Pharmaceuticals Inc | -- |